PharmaCorp Rx Inc. (TSXV:PCRX)
0.620
+0.020 (3.33%)
Feb 20, 2025, 4:00 PM EST
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 64.49 million as of February 21, 2025.
Market Cap
64.49M
Enterprise Value
39.06M
Revenue
1.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 64.49M, an increase of 2,587.11%. That is a compound annual growth rate of 294.04%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 64.49M | 1.85% |
Dec 31, 2024 | 63.32M | 427.65% |
Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Royal Bank of Canada | 239.70B |
The Toronto-Dominion Bank | 149.81B |
Brookfield Asset Management | 137.99B |
Enbridge | 129.57B |
Brookfield | 128.28B |
Thomson Reuters | 112.67B |
Bank of Montreal | 104.38B |
Constellation Software | 103.21B |